Literature DB >> 9459314

Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.

H P Kohler1, A M Carter, M H Stickland, P J Grant.   

Abstract

Little data is available regarding the activated form of factor XIIa (FXIIa) in survivors of myocardial infarction. 292 Caucasian patients characterised for extent of coronary atheroma by angiography and for a past history of myocardial infarction and 77 healthy controls were included in the study. To investigate the relationship between coronary artery disease, activated factor XII and other circulating factors, we studied levels of FXIIa, cholesterol, triglycerides, fasting insulin, fibrinogen, FVII:C, t-PA antigen and PAI-1 antigen. Factor XIIa levels were higher in all patients [2.5 (2.3-2.6) ng/ml] and in patients with a history of MI [2.6 (2.4-2.9) ng/ml] than in controls [1.9 (1.7-2.1) ng/ml], p < 0.0001. In patients, FXIIa levels positively correlated with FVII:C, BMI, cholesterol, insulin, PAI-1 antigen, t-PA antigen and triglycerides. In controls FXIIa levels only correlated with PAI-1 antigen and triglycerides. FXIIa levels were strongly associated with extent of coronary stenosis: 2.8 (2.6-3.1) ng/ml and 2.6 (2.3-2.9 ng/ml) in those with 2 and 3 vessels stenosed compared to 2.1 (1.9-2.3) ng/ml in those with 0 vessel stenosed (p = 0.0004). Activated FXII relates to both extent of coronary atheroma and to a past history of myocardial infarction and clusters with features of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459314

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI).

Authors:  Volker Pönitz; David Pritchard; Heidi Grundt; Mai-Britt Mehus; Dennis Winston T Nilsen
Journal:  J Thromb Thrombolysis       Date:  2007-05-11       Impact factor: 2.300

2.  Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.

Authors:  Alexey S Revenko; Dacao Gao; Jeff R Crosby; Gourab Bhattacharjee; Chenguang Zhao; Chris May; David Gailani; Brett P Monia; A Robert MacLeod
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

3.  Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia.

Authors:  J C Souto; L Almasy; M Borrell; F Blanco-Vaca; J Mateo; J M Soria; I Coll; R Felices; W Stone; J Fontcuberta; J Blangero
Journal:  Am J Hum Genet       Date:  2000-10-19       Impact factor: 11.025

4.  Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.

Authors:  Daria Zamolodchikov; Zu-Lin Chen; Brooke A Conti; Thomas Renné; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

5.  A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.

Authors:  Volker Pönitz; José W Govers-Riemslag; Hugo Ten Cate; Rene van Oerle; Trygve Brügger-Andersen; Heidi Grundt; Patrycja Næsgaard; David Pritchard; Alf I Larsen; Dennis W Nilsen
Journal:  Thromb J       Date:  2010-04-15

Review 6.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

7.  Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride.

Authors:  Rolf Dario Frank; Ute Mueller; Regina Lanzmich; Jürgen Floege
Journal:  J Mater Sci Mater Med       Date:  2013-07-18       Impact factor: 3.896

8.  Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis.

Authors:  Gianfranco Lessiani; Angela Falco; Elvira Nicolucci; Giancarlo Rolandi; Giovanni Davì
Journal:  J Thromb Thrombolysis       Date:  2008-04-06       Impact factor: 2.300

9.  Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats.

Authors:  Peter C Papageorgiou; Erik L Yeo; Peter H Backx; John S Floras
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

10.  Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects.

Authors:  Mikhail A Panteleev; Hendrik Coenraad Hemker
Journal:  Thromb J       Date:  2015-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.